(MedPage Today) — DENVER — A daily, single-tablet combination of bictegravir and lenacapavir (Yeztugo) was noninferior to complex multi-tablet regimens at maintaining virological suppression in people with HIV who can’t take currently available…
Source link : https://www.medpagetoday.com/meetingcoverage/croi/120091
Author :
Publish date : 2026-02-27 21:11:00
Copyright for syndicated content belongs to the linked Source.
